Patent Issued for Composition for the treatment of refractory painful intervertebral disc related disorders and method for delivery thereof to treat thereto (USPTO 11951084).

A patent has been issued for a composition and method for treating refractory painful intervertebral disc related disorders. The composition includes magnesium chloride and colchicine, which have vasodilating, antispasmodic, anti-inflammatory, and antioxidant properties. The treatment involves administering the composition via an intravenous drip over a course of 13-15 weeks. This non-invasive treatment option aims to reduce chronic spinal pain and is intended for patients who have not responded to other therapies. [Extracted from the article]